Geode Capital Management LLC lowered its stake in shares of Avantor, Inc. (NYSE:AVTR – Free Report) by 2.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,978,560 shares of the company’s stock after selling 317,126 shares during the quarter. Geode Capital Management LLC owned about 1.76% of Avantor worth $137,307,000 at the end of the most recent reporting period.
A number of other large investors have also added to or reduced their stakes in the stock. Terril Brothers Inc. acquired a new stake in Avantor during the fourth quarter worth approximately $124,000. Coldstream Capital Management Inc. boosted its holdings in shares of Avantor by 35.0% in the 4th quarter. Coldstream Capital Management Inc. now owns 18,592 shares of the company’s stock valued at $213,000 after purchasing an additional 4,822 shares in the last quarter. Leonteq Securities AG acquired a new stake in shares of Avantor in the 4th quarter valued at $68,000. North Dakota State Investment Board acquired a new stake in shares of Avantor in the 4th quarter valued at $268,000. Finally, DNB Asset Management AS acquired a new stake in shares of Avantor in the 4th quarter valued at $119,000. Institutional investors and hedge funds own 95.08% of the company’s stock.
Avantor Stock Up 5.0%
Shares of AVTR opened at $9.52 on Friday. Avantor, Inc. has a 52 week low of $7.26 and a 52 week high of $15.93. The stock has a market capitalization of $6.50 billion, a price-to-earnings ratio of -11.75, a PEG ratio of 5.26 and a beta of 0.97. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.17 and a current ratio of 1.76. The stock has a fifty day moving average of $8.15 and a 200-day moving average of $9.68.
Analyst Ratings Changes
A number of brokerages have weighed in on AVTR. Wall Street Zen downgraded Avantor from a “buy” rating to a “hold” rating in a report on Saturday, May 30th. UBS Group reaffirmed a “neutral” rating and issued a $10.50 target price on shares of Avantor in a report on Thursday, February 12th. Evercore set a $10.00 target price on Avantor in a report on Wednesday, February 11th. Royal Bank Of Canada began coverage on Avantor in a report on Thursday, May 14th. They issued a “sector perform” rating and a $9.00 target price on the stock. Finally, Robert W. Baird set a $11.00 target price on Avantor in a report on Thursday, February 12th. Two investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Reduce” and an average price target of $10.57.
Get Our Latest Analysis on AVTR
Insider Buying and Selling
In related news, Director Simon Dingemans bought 25,000 shares of the stock in a transaction that occurred on Friday, May 1st. The stock was acquired at an average cost of $8.14 per share, with a total value of $203,500.00. Following the transaction, the director directly owned 25,000 shares in the company, valued at approximately $203,500. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Sanjeev K. Mehra bought 125,000 shares of the stock in a transaction that occurred on Tuesday, March 10th. The shares were bought at an average cost of $8.01 per share, with a total value of $1,001,250.00. Following the completion of the transaction, the director owned 475,000 shares in the company, valued at $3,804,750. The trade was a 35.71% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders purchased a total of 160,000 shares of company stock valued at $1,287,950 in the last three months. Insiders own 0.28% of the company’s stock.
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
See Also
- Five stocks we like better than Avantor
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
